Successful immunotherapy with matrix metalloproteinase-derived peptides in adjuvant arthritis depends on the timing of peptide administration

Arthritis research

Volumn 4, Issue 4, 2002, Pages R2-

  van Bilsen, Jolanda H M ^a   Wagenaar Hilbers, Josée P A ^a   van der Cammen, Maarten J F ^a   van Dijk, Mariska E A ^a   van Eden, Willem ^a   Wauben, Marca H M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; PEPTIDE; STROMELYSIN;

ANIMAL; ARTHRITIS, EXPERIMENTAL; DRUG EFFECTS; IMMUNOLOGY; IMMUNOTHERAPY; INTRANASAL DRUG ADMINISTRATION; LEWIS RAT; MALE; PATHOPHYSIOLOGY; PROCEDURES; RAT; T LYMPHOCYTE; TIME; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ANIMALS; ARTHRITIS, EXPERIMENTAL; IMMUNOTHERAPY; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES; PEPTIDES; RATS; RATS, INBRED LEW; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME;

EID: 34247623962     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar421     Document Type: Article

References (0)